Distributive Shock
📧 Sign up to get email alerts when something new happens for Distributive Shock.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS approval · 2018-03-08Clinical Trial Update: Expanded Access for LJPC-501
La Jolla Pharmaceutical Company's LJPC-501 has been approved for marketing to treat catecholamine-resistant hypotension and distributive sho…
-
FDA approval · 2017-12-21FDA Approved: GIAPREZA — Original Application (La Jolla Pharmaceutical Company)
GIAPREZA (angiotensin II) was approved to increase blood pressure in adults with septic or other distributive shock.